SCHEMBL4618286

SCHEMBL4618286

Cc1ccc(S(=O)(=O)c2ccc(F)cc2)cc1S(=O)(=O)NCCc1ccc(Cl)cc1Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SFRP1 Q8N474 1/20 0.55
▸ KDM4E B2RXH2 2/20 0.45
▸ ALDH1A1 P00352 5/20 0.43
▸ MAPT P10636 5/20 0.42
▸ HMOX1 P09601 1/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ LMNA P02545 3/20 0.42
▸ TP53 P04637 2/20 0.42
▸ PKM P14618 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ IDH1 O75874 1/20 0.41
▸ POLB P06746 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ TAAR1 Q96RJ0 1/20 0.40
▸ PDK1 Q15118 1/20 0.40
▸ PDK2 Q15119 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6102921 0.93 SFRP1 (0.59) SFRP1KDM4EALDH1A1MAPTNPC1
SCHEMBL4617530 0.91 SFRP1 (0.57) SFRP1ALDH1A1MAPTNPC1LMNA
SCHEMBL4617387 0.90 SFRP1 (0.68) SFRP1KDM4EALDH1A1MAPTNPC1
SCHEMBL4617783 0.88 SFRP1 (0.61) SFRP1KDM4EMAPTLMNATP53
SCHEMBL4618849 0.86 SFRP1 (0.67) SFRP1ALDH1A1MAPTLMNATP53
SCHEMBL4616020 0.86 SFRP1 (0.67) SFRP1ALDH1A1MAPTLMNATP53
SCHEMBL4615418 0.84 SFRP1 (0.64) SFRP1ALDH1A1MAPTLMNATP53
SCHEMBL6102394 0.83 SFRP1 (0.67) SFRP1ALDH1A1MAPTLMNATP53
SCHEMBL4615997 0.83 SFRP1 (0.60) SFRP1KDM4EALDH1A1MAPTLMNA
SCHEMBL4618887 0.82 SFRP1 (0.75) SFRP1KDM4EALDH1A1TP53PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 — — EP claimed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 — — US claimed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 — — WO claimed
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 — — EP disclosed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 — — US disclosed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 SFRP1 1/4885KDM4E 3044/4885ALDH1A1 1865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback